Analysis of Transphorm Inc (TGAN)
Transphorm Inc (TGAN) has been showing some interesting price movements and technical indicators in the past few days:
1. Price Movement:
- The closing prices have been fluctuating between 4.780 and 4.910.
- The stock seems to be trading in a relatively narrow range.
2. Relative Strength Index (RSI):
- The RSI values have been fluctuating between 32.82 and 59.43.
- The RSI values indicate that the stock has been moving between being oversold and overbought.
3. Moving Average Convergence Divergence (MACD):
- The MACD line has been fluctuating around the signal line, indicating potential changes in momentum.
- The MACD histogram has been mostly negative, suggesting a bearish momentum.
4. Moving Averages:
- The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend.
Overall, Transphorm Inc (TGAN) seems to be experiencing some volatility in its price movements, with technical indicators showing mixed signals. Traders and investors may want to closely monitor the stock for potential trading opportunities.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures. The increase in the number of analysts providing estimates for the future periods indicates continued interest and attention from the investment community.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight increase in growth rate expected in the near future compared to the current period. However, the projected growth rates for the next year and the next 5 years are lower than the average growth rate achieved in the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were reported after hours. The results from October 31, 2024, were not provided at the time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a current ratio slightly above 1, indicating good liquidity, but a high total debt to equity ratio. The income statement reveals significant revenue and EBITDA, with a positive diluted EPS and net income to common ratio. The company experienced a slight decline in quarterly revenue and earnings growth year over year.
Moving on to stock statistics, the company has a low short ratio and short percent of shares outstanding, with a significant percentage held by institutions. The stock price summary shows a beta above 1, with the stock trading within a range between its fifty-two-week low and high.
Valuation metrics indicate a high PEG ratio and price to book ratio, with the stock trading at a relatively high forward and trailing PE. The enterprise value, market capitalization, and other ratios suggest the stock may be considered overvalued.
Lastly, the dividends and splits information shows a moderate payout ratio, with details on dividend dates, split history, and dividend yields. The company has a consistent dividend payment history and a relatively low dividend yield compared to its stock price.
Income statement 💸
These are the revenues. Draw conclusions.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in non-current assets, possibly for long-term growth and sustainability.
7. There is a consistent level of short-term debt and accounts payable, which the company manages effectively.
8. The accumulated depreciation on non-current assets suggests ongoing investments in infrastructure.
9. Overall, the company seems to be in a stable financial position with a focus on growth and shareholder value.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows growth compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth compared to the EPS of $1.35 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the EPS of $5.67 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests growth compared to the EPS of $6.10 from the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.MACD of TGAN